<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02712190</url>
  </required_header>
  <id_info>
    <org_study_id>ANIV</org_study_id>
    <nct_id>NCT02712190</nct_id>
  </id_info>
  <brief_title>Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.</brief_title>
  <acronym>ANIV</acronym>
  <official_title>Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess the efficacy of high-frequency non-invasive ventilation
      on apnea duration, carbon dioxide clearance and oxygen delivery in healthy subjets and
      patients with lung disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High frequency ventilation (HF-V) allows to ensure oxygen delivery and carbon dioxide
      clearance despite the absence of thoracic movement in anesthetized, invasively ventilated
      subjects. This same technique could be applied by a non-invasive interface (HF-NIV), allowing
      to obtain a prolonged apnea (absence of thoraco-abdominal respiratory movements) in awaken
      subjects. Such an application would be of interest for several clinical applications, e.g.
      lung imaging and radio-therapy treatment on lung cancer. The purpose of the study is to
      assess the effect of different HF-NIV setting on the apnea duration, carbon dioxide clearance
      and oxygen delivery in healthy subjets and patients with lung diseases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of apnea</measure>
    <time_frame>1 study session (2 hours)</time_frame>
    <description>Duration of apnea according to the different settings of the HF-NIV, defined as absence of thoraco-abdominal respiratory movements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous carbon dioxide partial pressure</measure>
    <time_frame>1 study session (2 hours)</time_frame>
    <description>Evolution of transcutaneous carbon dioxide partial pressure (TcCo2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation of arterial blood</measure>
    <time_frame>1 study session (2 hours)</time_frame>
    <description>Evolution of oxygen saturation, measured by pulse-oximetry (SatO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung volume</measure>
    <time_frame>1 study session (2 hours)</time_frame>
    <description>Evolution of lung volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective tolerance</measure>
    <time_frame>1 study session (2 hours)</time_frame>
    <description>Subjective tolerance of the HF-NIV (questionnaire)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Non-invasive Ventilation</condition>
  <condition>High-frequency Ventilation</condition>
  <condition>Healthy Volunteer</condition>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Low - High frequence sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High-Frequency non-invasive ventilation (HF-NIV) with 2 different settings, sequence of respiratory rate 250/min and respiratory rate 500/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High - Low frequence sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High-Frequency non-invasive ventilation (HF-NIV) with 2 different settings, sequence of respiratory rate 500/min and respiratory rate 250/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-frequency non-invasive ventilation</intervention_name>
    <description>Comparison of 2 different settings of HF-NIV</description>
    <arm_group_label>Low - High frequence sequence</arm_group_label>
    <arm_group_label>High - Low frequence sequence</arm_group_label>
    <other_name>HF-NIV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy subjets : normal respiratory function and no known lung disease

          -  lung disease patients : chronic obstructive pulmonary disease, Sarcoidosis, Cystic
             fibrosis

          -  age &gt;=18y

        Exclusion Criteria:

          -  increased pneumothorax risk under positive pressure ventilation

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alban Lovis</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie - CHUV</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alban Lovis, MD</last_name>
    <email>alban.lovis@chuv.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adam Ogna, MD</last_name>
    <email>adam.ogna@chuv.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Pneumologie - Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alban Lovis, MD</last_name>
      <email>alban.lovis@chuv.ch</email>
    </contact>
    <contact_backup>
      <last_name>Adam Ogna, MD</last_name>
      <email>adam.ogna@chuv.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Alban Lovis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Ogna, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2016</study_first_submitted>
  <study_first_submitted_qc>March 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2016</study_first_posted>
  <last_update_submitted>July 24, 2017</last_update_submitted>
  <last_update_submitted_qc>July 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Adam Ogna</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

